Your browser doesn't support javascript.
loading
Progressive metastatic infantile fibrosarcoma with multiple acquired mutations.
Furtado, Larissa V; Kacar, Marija; Mostafavi, Roya; Shi, Zonggao; Ruiz, Robert; Koo, Selene C; Santiago, Teresa; Segers, Blair; Krasin, Matthew J; Abramson, Zachary R; Shulkin, Barry; Talbot, Lindsay J; Pappo, Alberto; Gartrell, Jessica.
Afiliación
  • Furtado LV; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Kacar M; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Mostafavi R; Division of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Shi Z; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Ruiz R; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Koo SC; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Santiago T; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Segers B; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
  • Krasin MJ; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Abramson ZR; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Shulkin B; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Talbot LJ; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Pappo A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
  • Gartrell J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA; jessica.gartrell@stjude.org.
Article en En | MEDLINE | ID: mdl-36997313
Infantile fibrosarcoma is the most common soft-tissue sarcoma in children under the age of 1 yr and is defined molecularly by NTRK fusion proteins. This tumor is known to be locally invasive; however, although rare, metastases can occur. The NTRK fusion acts as a driver for tumor formation, which can be targeted by first- and second-generation TRK inhibitors. Although NTRK gatekeeper mutations have been well-described as mechanisms of resistance to these agents, alternative pathway mutations are rare. Here, we report the case of a patient with infantile fibrosarcoma treated with chemotherapy and TRK inhibition that developed metastatic, progressive disease with multiple acquired mutations, including TP53, SUFU, and an NTRK F617L gatekeeper mutation. Alterations in pathways of SUFU and TP53 have been widely described in the literature in other tumors; however, not yet in infantile fibrosarcoma. Although most patients have a sustained response to TRK inhibitors, a subset will go on to develop mechanisms of resistance that have implications for clinical management, such as in our patient. We hypothesize this constellation of mutations contributed to the patient's aggressive clinical course. Taken together, we report the first case of infantile fibrosarcoma with ETV6::NTRK3 and acquired SUFU, TP53, and NTRK F617L gatekeeper mutation along with detailed clinical course and management. Our report highlights the importance of genomic profiling in recurrent infantile fibrosarcoma to reveal actionable mutations, such as gatekeeper mutations, that can improve patient outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias Primarias Secundarias / Fibrosarcoma Límite: Child / Humans Idioma: En Revista: Cold Spring Harb Mol Case Stud Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias Primarias Secundarias / Fibrosarcoma Límite: Child / Humans Idioma: En Revista: Cold Spring Harb Mol Case Stud Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos